De novo and bi-allelic variants in AP1G1 cause neurodevelopmental disorder with developmental delay, intellectual disability, and epilepsy

Muhammad A. Usmani, Zubair M. Ahmed, UCLA Clinical Genomics Center, Pamela Magini, Victor Murcia Pienkowski, Kristen J. Rasmussen, Rebecca Hernan, Faiza Rasheed, Mureed Hussain, Mohsin Shahzad, Brendan C. Lanpher, Zhiyv Niu, Foong Yen Lim, Tommaso Pippucci, Rafal Ploski, Verena Kraus, Karolina Matuszewska, Flavia Palombo, Jessica Kianmahd, Julian A. Martinez-AgostoHane Lee, Emma Colao, M. Mahdi Motazacker, Karlla W. Brigatti, Erik G. Puffenberger, S. Amer Riazuddin, Claudia Gonzaga-Jauregui, Wendy K. Chung, Matias Wagner, Matthew J. Schultz, Marco Seri, Anneke J.A. Kievit, Nicola Perrotti, J. S.Klein Wassink-Ruiter, Hans van Bokhoven, Sheikh Riazuddin, Saima Riazuddin*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

6 Citations (Scopus)

Fingerprint

Dive into the research topics of 'De novo and bi-allelic variants in AP1G1 cause neurodevelopmental disorder with developmental delay, intellectual disability, and epilepsy'. Together they form a unique fingerprint.

Medicine and Dentistry

Neuroscience

Pharmacology, Toxicology and Pharmaceutical Science

Biochemistry, Genetics and Molecular Biology

Immunology and Microbiology